Unusual clinical signs of primary hyperparathyroidism

被引:0
|
作者
Alonso Resendiz-Colosia, Jaime [1 ]
Arturo Rodriguez-Cuevas, Sergio [1 ]
Elena Medrano-Ortiz de Zarate, Maria [2 ]
Flores-Diaz, Rutilio [1 ]
Francisco Gallegos-Hernandez, Jose [1 ]
Gomez-Acosta, Fernando [1 ]
机构
[1] Hosp Oncol, Ctr Med Nacl Siglo 21, Serv Tumores Cabeza Cuello & Piel, Inst Mexicano Seguro Social, Mexico City 06725, DF, Mexico
[2] Hosp Oncol, Ctr Med Nacl Siglo 21, Serv Endocrinol, Inst Mexicano Seguro Social, Mexico City 06725, DF, Mexico
来源
GACETA MEDICA DE MEXICO | 2009年 / 145卷 / 03期
关键词
Primary hyperparathyroidism; brown tumors; osteitis fibrosa cystica; OSTEITIS FIBROSA CYSTICA; MULTIPLE BROWN TUMORS; PARATHYROIDECTOMY; ASSOCIATION; CARCINOMA; SURGERY;
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background: A growing number of patients with primary hyperparathyroidism (PHPT) are diagnosed in the absence of symptoms following routine biochemical screening. However, in some countries, overt manifestations and osteitis fibrosa cystica (OFC) still dominate the clinical profile of PHPT patients. Methods: We retrospectively studied clinical and biochemical manifestations of 47 consecutive patients with primary hyperparathyroidism who were treated with parathyroidectomy from October 1993 to June 2005. Results: Mean age was of 51.3 years, Our sample included 40 women (85%) and 7 men (15%). Seventy eight percent of cases had radiological features of OFC, namely subperiosteal bone resorption, cortical cysts and osteopenia. Pathological fracture occurred in nine patients (19.1%). Fifteen (32%) patients had clinically evident bony deformities or brown tumors mostly located in the mandible and maxilla. Conclusions: Our results indicate that symptomatic osteitis fibrosa cystica and severe decrease of bone mineral density were the primary manifestations of primary hyperparathyroidism. Most patients were referred to an oncology hospital for treatment due to a suspected malignant neoplasm. A comprehensive clinical evaluation with biochemical markers, imaging studies and histological results is needed to establish a possible diagnosis of primary hyperparathyroidism.
引用
下载
收藏
页码:207 / 213
页数:7
相关论文
共 50 条
  • [31] PRIMARY HYPERPARATHYROIDISM - CHANGE OF A CLINICAL SYNDROME
    RAUE, F
    JACUBEIT, T
    MINNE, H
    HERFARTH, C
    ZIEGLER, R
    MEDIZINISCHE KLINIK, 1989, 84 (04) : 178 - 182
  • [32] PRIMARY HYPERPARATHYROIDISM - PROSPECTIVE CLINICAL STUDY
    PURNELL, DC
    SMITH, LH
    SCHOLZ, DA
    ELVEBACK, LR
    ARNAUD, CD
    AMERICAN JOURNAL OF MEDICINE, 1971, 50 (05): : 670 - &
  • [33] CLINICAL AND BIOCHEMICAL FEATURES IN PRIMARY HYPERPARATHYROIDISM
    NIKKILA, MT
    SAARISTO, JJ
    KOIVULA, TA
    SURGERY, 1989, 105 (02) : 148 - 153
  • [34] CLINICAL AND BIOCHEMICAL FEATURES OF PRIMARY HYPERPARATHYROIDISM
    KAPUR, MM
    AGARWAL, MS
    GUPTA, A
    MISRA, MC
    AHUJA, MMS
    INDIAN JOURNAL OF MEDICAL RESEARCH, 1985, 81 (JUN) : 607 - 612
  • [35] Primary hyperparathyroidism: Epidemiology and clinical consequences
    Bilezikian J.P.
    Silverberg S.J.
    Clinical Reviews in Bone and Mineral Metabolism, 2002, 1 (1): : 25 - 34
  • [36] PRIMARY HYPERPARATHYROIDISM - CLINICAL AND BIOCHEMICAL FEATURES
    MALLETTE, LE
    BILEZIKI.JP
    HEATH, DA
    AURBACH, GD
    MEDICINE, 1974, 53 (02) : 127 - 146
  • [37] CLINICAL MANAGEMENT OF PERSISTENT PRIMARY HYPERPARATHYROIDISM
    BUHR, HJ
    FLENTJE, D
    FISCHER, S
    HERFARTH, C
    LANGENBECKS ARCHIV FUR CHIRURGIE, 1990, : 987 - 990
  • [38] Clinical update: sporadic primary hyperparathyroidism
    Sitges-Serra, Antonio
    Bergenfelz, Anders
    LANCET, 2007, 370 (9586): : 468 - 470
  • [39] Molecular and Clinical Spectrum of Primary Hyperparathyroidism
    Jha, Smita
    Simonds, William F.
    ENDOCRINE REVIEWS, 2023, 44 (05) : 779 - 818
  • [40] MEDICAL ASPECTS OF PRIMARY HYPERPARATHYROIDISM CLINICAL
    DENT, CE
    DAVIES, DR
    PROCEEDINGS OF THE ROYAL SOCIETY OF MEDICINE-LONDON, 1959, 52 (11): : 993 - 995